Synthetic Biology Market: By Tools ; By Technology ; By Application ; By Geography- Forecast 2019-2025

出版商 IndustryARC 商品編碼 622687
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
Back to Top
合成生物學市場預測:XNAS·底盤有機體·寡核甘酸等 Synthetic Biology Market: By Tools ; By Technology ; By Application ; By Geography- Forecast 2019-2025
出版日期: 2018年12月30日內容資訊: 英文


第1章 市場概要

第2章 摘要整理

第3章 市場環境

  • 市場佔有率分析
  • 終端用戶的分析
  • 競爭經營者的基準
  • 財務分析

第4章 市場影響因素

  • 成長推進因素
  • 阻礙成長要素·課題
  • 市場魅力

第5章 策略性市場分析

  • 價值鏈分析
  • 價格分析
  • 市場機會分析
  • 市場生命週期

第6章 合成生物學市場分析·預測:各工具

  • 簡介
  • XNAS
  • 底盤有機體
  • 寡核甘酸
  • 基因複製技術套組
  • 酵素

第7章 合成生物學市場分析·預測:各技術

  • 簡介
  • DNA合成
  • DNA定序
  • computer model
  • 生物資訊學技術
  • 微流體技術
  • 奈米技術
  • 通路技術
  • 其他

第8章 合成生物學市場分析·預測:各用途

  • 簡介
  • 環境
    • 生物修復
    • 全細胞生物傳感器
  • 醫療
    • 藥物研發·治療
    • 醫藥品
    • 人工組織·組織再生
  • 工業用途
    • 生質燃料·再生能源
    • 產業用酵素
    • 生物材料·綠色化學

第9章 合成生物學市場分析·預測:各地區

  • 簡介
  • 南北美洲
    • 美國
    • 加拿大
    • 墨西哥
    • 巴西
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他
  • 亞太地區
    • 中國
    • 韓國
    • 日本
    • 印度
    • 其他
  • 其他
    • 中東
    • 非洲

第10章 市場熵

第11章 企業簡介

  • Ingenza Ltd
  • Intrexon Corporation
  • Ziopharm Oncology Inc
  • Cargill Incorporated
  • Novozymes
  • OriGene Technologies, Inc
  • Green Biologics Limited
  • Evolva
  • Codexis, Inc.
  • Halozyme Inc.
  • Integrated DNA Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Algenol Biotech
  • Amyris Inc
  • BioAmber Inc



Synthetic Biology Market Overview

Synthetic biology is an emerging area of biological research which combines both science and engineering. According to this research report from IndustryARC, the global synthetic biology market size was between $12.80 billion to $13.86 billion in 2018, and the market demand is projected to grow at a phenomenal CAGR of 36% to 38% during the forecast period of 2019 to 2025. North America is identified as the key region, chunking out 41% to 43% of the total demand in 2018 and poised to maintain its dominance. Factors such as increasing investment to harness possibilities with new synthetic biology technologies such as gene synthesis, genome engineering, cloning, sequencing, and nanotechnology, growing R&D funding, and collaborations are driving the growth of the synthetic biology market in this region.

Synthetic Biology Market Outlook

Analyst of the report says that, bio medicine and health care application is dominating among other diverse applications such as industrial, and environmental; it is estimated to grow with an exuberant CAGR of 40% to 42% during the forecast period 2019-2025. According to International Diabetes Federation, in North America, 45.9 million adults aged 20-29 years were living with diabetes in 2017, representing a regional frequency of 13%, among all IDF regions. Synthetic biology offering a platform for the future medicines, where cells can fight with diseases such as diabetes and cancer; which is propelling the abundant demand for the synthetic biology market during the forecast period of 2019 to 2025.

Synthetic Biology Market Growth Drivers

As world population is increasing day by day, conversely, the need for food is also increasing and the cultivation land is decreasing owing to industrialization. Using synthetic biology techniques, farmers can yield more crops in low cultivation land due to their properties such as more efficient plant use of water and nutrients, photosynthetic performance, nitrogen fixation and better resistance to pests are developed using synthetic biology.

Artemisinin is an antimalarial medicine which will be now produced from yeast using synthetic biology; avoiding the need to isolate it from Chinese sweet wormwood plant. This will help to stabilize global medicine prices and increases and the demand for synthetic biology market in the medical sector.

Globally, cancer is the second leading cause of death which is responsible for an estimated 9.6 million deaths in 2018. According to World Health Organization, about 1 in 6 deaths are due to cancer. Advancement in genome engineering such as CRISPR and DNA synthesis technologies will reduce the risks from cancer and driving the growth of the synthetic biology market.

Synthetic Biology Market Challenges

The construction and testing process of biological systems is complicated and irregular; which became the major challenge for the growth of the market. However, to solve this problem, Ginkgo Biological Studio developed an automation system which can combine the gene components together.

The misuse of synthetic biology or possibilities of accidental release of pathogens into free atmosphere is another key challenge for the market. But, rising demand for bio-fuels, and investments on synthetic drugs and vaccines would further offer profitable growth chances in the market.

In order to create larger functional architecture by synthetic biology, device modularization and standardization become a necessity. However, the non-linear and uncertain nature of systems biology makes standardization of parts as a non-trivial task which in turn propels the growth of the market.

Synthetic Biology Market

Synthetic Biology Market Key Players Perspective

In 2018, Thermo Fisher Scientific, Inc., a leading global life sciences company has licensed its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technologies from the Board Institute and ERS Genomics University of California to enhance its genome editing intellectual property (IP) portfolio. Helge Bastian, vice president and general manager of synthetic biology at Thermo Fisher says that, the reason behind this enhancement is to further unravel the function of DNA elements and genes in the development of new drugs and cell therapies.

Some of the other players mentioned in this report are GenScript, Integrated DNA Technologies, Inc., OriGene Technologies, Inc., ATUM, Synthetic Genomics, Inc., Pareto Biotechnologies, Inc., and Blue Heron Biotech, LLC,

Synthetic Biology Market Trends

Biomonitoring is another exciting area for synthetic biology developments. Highly specific, tiny biosensors can be engineered to spot an enormous range of molecules such as hydrocarbon pollutants, sugars, heavy metals, and antibiotics in environmental sensing systems.

Synthetic biology also used in agricultural applications to provide more precision and sophistication than earlier gene technologies. This helps to increase crop and livestock yields, while reducing environmental impact by limiting the use of chemicals and fertilizers.

OPX Biotechnologies (OPXBIO) is developing renewable bio based acrylic to match petro-acrylic performance and cost but with a 75 percent reduction in greenhouse gas emissions. BioAcrylic from OPXBIO also will reduce oil-dependence and offer more stable prices.

Synthetic Biology Market Research Scope

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the synthetic biology market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of synthetic biology market, and their specific applications in different types of vehicles.

Synthetic Biology Market Report Industry Coverage

Types of Tools in Synthetic Biology: Xeno-Nucleic Acid, Chassis Organisms, Oligonucleotides, Cloning Technology Kits, and Enzymes

Applications of Synthetic Biology: Environmental, Medical, and Industrial

Technologies of Synthetic Biology: DNA Synthesis, DNA Sequencing, and Computational Modelling

The Synthetic Biology market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

Middle East and Africa: Israel, South Africa, Saudi Arabia

1. Market Overview

2. Executive Summary

3. Synthetic Biology Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
    • 3.2.1. Product Benchmarking
    • 3.2.2. End user Profiling
    • 3.2.3. Top 5 Financials Analysis

4. Synthetic Biology Market -Forces

  • 4.1. Market Drivers
  • 4.2. Market Constraints & Challenges
  • 4.3. Attractiveness of the Solenoid Valve Industry
    • 4.3.1. Power of Suppliers
    • 4.3.2. Threats From New Entrants
    • 4.3.3. Power of Buyer
    • 4.3.4. Threat From Substitute Product
    • 4.3.5. Degree of Competition

5. Synthetic Biology Market -Strategic Analysis

  • 5.1. Solenoid Valve Market - Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunity Analysis
  • 5.4. Product Life Cycle
  • 5.5. Suppliers and Distributors
  • 5.6. SWOT Analysis

6. Synthetic Biology Market- By Tool

  • 6.1. Xeno-Nucleic Acids (Xnas)
  • 6.2. Chassis Organisms
  • 6.3. Oligonucleotides
  • 6.4. Cloning Technology Kits
  • 6.5. Enzymes

7. Synthetic Biology Market- By Products

  • 7.1. Introduction
  • 7.2. Enabling Products
    • 7.2.1. DNA Synthesis
    • 7.2.2. Oligonucleotide Synthesis
  • 7.3. Core Products
    • 7.3.1. Synthetic DNA
    • 7.3.2. Synthetic Genes
    • 7.3.3. Synthetic Cells
    • 7.3.4. Chassis organisms XNA
  • 7.4. Enabled Products
    • 7.4.1. Pharmaceutical and Diagnostics
    • 7.4.2. Chemicals
    • 7.4.3. Biofuels
    • 7.4.4. Agriculture

8. Synthetic Biology Market- By Technology

  • 8.1. Introduction
  • 8.2. Bio informatics Technologies
  • 8.3. DNA sequencing
  • 8.4. Genome Engineering
  • 8.5. Microfluidics Technologies
  • 8.6. Biological Components
  • 8.7. Integrated Systems
  • 8.8. Pathway Engineering
  • 8.9. Synthetic Microbial Consortia
  • 8.10. Biofuel Technologies
  • 8.11. Next Generation Sequencing
  • 8.12. Nanotechnology
  • 8.13. Cloning and Sequencing
  • 8.14. Others

9. Synthetic Biology Market- By Application

  • 9.1. Introduction
  • 9.2. Agriculture
  • 9.3. Biofuel
  • 9.4. Medicine
  • 9.5. Environmental Application
  • 9.6. Chemical
  • 9.7. Food
  • 9.8. Industrial Enzyme
  • 9.9. Biological Electrics
  • 9.10. Personal Care
  • 9.11. Others

10. Synthetic Biology Market -By Geography

  • 10.1. Americas
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Mexic
    • 10.1.4. Brazil
  • 10.2. Europe
    • 10.2.1. U.K.
    • 10.2.2. Germany
    • 10.2.3. Italy
    • 10.2.4. Rest of Europe
  • 10.3. Asia Pacific
    • 10.3.1. China
    • 10.3.2. South Korea
    • 10.3.3. Japan
    • 10.3.4. India
    • 10.3.5. Russia
    • 10.3.6. Rest of APAC
  • 10.4. Rest of The World (RoW)
    • 10.4.1. Middle East
    • 10.4.2. Africa

11. Synthetic Biology Market-Entropy

  • 11.1. New Product Developments
  • 11.2. Product Launchers, JVS, Mergers and Acquisitions

12. Company Profiles

  • 12.1. Algenol Biofuels Inc.
  • 12.2. Allylix, Inc.,
  • 12.3. Amyris
  • 12.4. BASF
  • 12.5. BioAmber
  • 12.6. Codexis, Inc.
  • 12.7. DNA2.0, Inc.
  • 12.8. Evolva
  • 12.9. GEN9 Inc.
  • 12.10. GeneArt (Life Technologies)
  • 12.11. Green Biologics Limited
  • 12.12. Halozyme
  • 12.13. Integrated DNA Technologies, Inc.
  • 12.14. Invista
  • 12.15. Twist Bioscience
  • 12.16. Verdezyne
  • 12.17. Ziopharm
  • 12.18. Thermo Fisher Scientific, Inc.
  • 12.19. Novozymes
  • 12.20. Oakbio
  • 12.21. OPX Biotechologies
  • 12.22. OriGene Technologies, Inc

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

Back to Top